A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Aim: To examine the safety and efficacy of modafinil (200 mg/day) compared to placebo in the treatment of methamphetamine dependence and to examine predictors of post-treatment outcome. Participants and design: Eighty methamphetamine-dependent subjects in Sydney, Australia were allocated randomly to modafinil (200 mg/day) (n = 38) or placebo (n = 42) under double-blind conditions for 10 weeks with a further 12 weeks post- treatment follow-up. Measures: Comprehensive drug use data (urine...[Show more]
|Collections||ANU Research Publications|
|01_Shearer_A_double-blind,_2009.pdf||231.99 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.